Are Both Meningococcal Vaccines Equally Effective
The MCV4, MPSV4 and MenB vaccines are about 85-90% effective in preventing meningococcal disease. There are actually several types of N meningitidis — the bacterium that causes meningococcal disease, five of which are common in the U.S. These vaccines together protect against all five of these strains.
MCV4 has not been available long enough to compare the long-term effectiveness of the two vaccines. But most experts think that MCV4 provides better, longer-lasting protection.
Why Teenagers And Students Should Have The Menacwy Vaccine
Meningococcal disease is a rare but life-threatening disease caused by meningococcal bacteria.
Older teenagers and new university students are at higher risk of infection because many of them mix closely with lots of new people, some of whom may unknowingly carry the meningococcal bacteria at the back of their nose and throat.
Anyone who is eligible for the MenACWY vaccine should have it, even if they have previously had the MenC vaccine.
The MenACWY vaccine is highly effective in preventing illness caused by the 4 meningococcal strains, including the extremely harmful MenW strain.
What Are The Risks Of Gbs With The Mcv4 Vaccine
Between 2005 and 2012, more than 18 million doses of MCV4 were distributed. It’s uncertain how many of those have actually been given. In that same time period, there have been 99 confirmed cases of GBS, a serious nervous system disorder, reported within six weeks of the vaccine being taken. There is not enough data at this time to tell whether or not the vaccine was a factor. But analysis of the data suggests that the incidence of GBS is no higher for people receiving the vaccine than the incidence of GBS in the general population.
Still, the timing of the onset of symptoms has raised concern. The CDC is continuing to study the issue and has recommended that people be told about the study when they are considering the vaccine. The current opinion is that even if there is a slight increase in the risk of GBS, it’s significantly outweighed by the risk of meningococcal disease without the vaccine.
Talk to your doctor if you have any further concerns about the vaccine and GBS.
Show Sources
Pediatrics, published online Feb. 1, 2011. CDC web site: “Meningitis Questions & Answers,” “Meningococcal Vaccines: What You Need to Know,” “Meningococcal Vaccination,” “Vaccines and Preventable Diseases: Meningococcal: Who Needs to Be Vaccinated?” “Meningococcal vaccine side-effects,” “GBS and Menactra Meningococcal Vaccine.”
VaccineInformation.org: “Meningococcal Disease Vaccine.”
Read Also: Does Cvs Give Tetanus Shots
Are You Still At Risk Of Meningitis After The Immunisation
Yes. However, the MenC vaccine has greatly reduced the number of cases of meningitis and blood infection since it was introduced in 1999 and the MenB vaccine is expected to be as effective.
Note: other groups of meningococcus, and other germs can still cause meningitis.
You should get medical help immediately if you suspect that your child, or someone you know, has meningitis or septicaemia. The earlier the treatment of meningitis or septicaemia, the better the chance of recovery and preventing complications or death. See the separate leaflet called Meningitis. See also the separate leaflets called and Meningitis Symptoms Checklist for more details about the symptoms of meningitis and septicaemia.
Meningococcal Disease In Australia

Meningococcal disease can occur sporadically or in epidemics. In Australia, most cases occur during winter and early spring. Other countries with temperate climates also have this seasonal trend.95
The meningococcal serogroups that cause meningococcal disease have been changing. A meningococcal C vaccine was introduced on the National Immunisation Program in 2003 and has resulted in a large reduction in meningococcal C disease incidence.95,96
Meningococcal B has historically caused most meningococcal disease in Australia.96 Meningococcal B continues to cause around half of all reported cases of meningococcal disease in Australia.98
Meningococcal B is most common in South Australia, where a state-funded MenB vaccination program was introduced from 2018. Refer to the South Australian Health Department website for further details.
Because of substantial declines in invasive meningococcal disease caused by serogroups B and C, overall IMD incidence in Australia declined between 2003 and 2013.96
Since 2013, the incidence of meningococcal W disease has rapidly increased.98,99 Incidence of meningococcal Y disease has also been steadily increasing since 2016.98 Several states and territories implemented vaccination programs with MenACWY vaccine in 2017 to manage this disease. In 2018, MenACWY vaccine was introduced on the National Immunisation Program for toddlers aged 12 months. Adolescents are able to receive MenACWY vaccine on the National Immunisation Program from 2019.
Also Check: Does Cvs Give Tdap Shots
Menacwy Vaccine Side Effects
Like all vaccines, the MenACWY vaccine can cause side effects, but they are generally mild and soon pass.
The most common side effects seen in teenagers and young people are redness, hardening and itching at the injection site, a high temperature , headache, feeling sick and tiredness . These symptoms should last no longer than 24 hours.
Sometimes a small, painless lump develops, but this usually disappears after a few weeks.
Simultaneous Administration With Other Vaccines
Men-C-C and 4CMenB vaccine may be administered concomitantly with routine childhood vaccines, and Men-C-ACYW vaccine may be administered concomitantly with adolescent and adult age appropriate vaccines. MenB-fHBP can be given concomitantly with quadrivalent human papillomavirus vaccine meningococcal serogroup A, C, Y, W conjugate vaccine and tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed. The concomitant administration of MenB-fHBP has not been studied with other vaccines.
Men-C-ACYW-CRM can be administered with routine paediatric vaccines however, further studies are needed with regard to concomitant administration with pneumococcal 13-valent conjugate vaccine. Co-administration of Men-C-ACYW-CRM and combined tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine may result in a lower immune response to the pertussis antigens than when Tdap vaccine is given alone however, the clinical significance of this is unknown. Tdap vaccine given one month after Men-C-ACYW-CRM induces the strongest immunologic response to pertussis antigens.
If vaccines are to be administered concomitantly with another vaccine, a separate injection site and a different syringe must be used for each injection.
Refer to Timing of Vaccine Administration in Part 1 for additional general information.
You May Like: Cvs Pharmacy Tdap
Young People Starting University Aged 25 Or Under
Various sub groups of meningococcal disease can spread quickly in areas where people live closely to each other:
- in university halls of residence
- in shared accommodation
If youre aged 25 or under, about to start university for the first time and havent yet had the MenACWY vaccination, you should ask your GP for the vaccine. Even if you have previously received the Men C vaccine you should still now ask for the MenACWY vaccine.
Ideally, you should get the vaccine at least two weeks before you start university. If you dont get the vaccine before going to university you should contact a GP in the university health centre and arrange to get the vaccine.
You can ask your GP, practice nurse or university health centre for more information about the vaccine.
What If There Is A Severe Reaction
An allergic reaction could occur after the vaccinated person leaves the clinic. If you see signs of a severe allergic reaction , call 9-1-1 and get the person to the nearest hospital.
For other signs that concern you, call your health care provider.
Adverse reactions should be reported to the Vaccine Adverse Event Reporting System . Your health care provider will usually file this report, or you can do it yourself. Visit the VAERS website at or call . VAERS is only for reporting reactions, and VAERS does not give medical advice.
Don’t Miss: Cheapest Shingles Vaccine
Historic Dates And Events Related To Vaccines And Immunization
It was not too many years ago when we celebrated the 200th anniversary of Edward Jenner’s first smallpox vaccination in 1796. The development of vaccines continued at a fairly slow rate until the last several decades when new scientific discoveries and technologies led to rapid advances in virology, molecular biology, and vaccinology. The chart which follows displays many of the vaccine- and immunization-related events that have occurred since Jenner’s critical discovery. This list is by no means exhaustive. If you know of an event that you would like us to add, contact us at . |
What Is Meningococcal Disease
Meningococcal ACWY vaccine can help protect against meningococcal disease caused by serogroups A, C, W, and Y. A different meningococcal vaccine is available that can help protect against serogroup B.
Meningococcal disease can cause meningitis and infections of the blood. Even when it is treated, meningococcal disease kills 10 to 15 infected people out of 100. And of those who survive, about 10 to 20 out of every 100 will suffer disabilities such as hearing loss, brain damage, kidney damage, loss of limbs, nervous system problems, or severe scars from skin grafts.
Meningococcal disease is rare and has declined in the United States since the 1990s. However, it is a severe disease with a significant risk of death or lasting disabilities in people who get it.
Anyone can get meningococcal disease but certain people are at increased risk, including:
- Infants younger than one year old
- Adolescents and young adults 16 through 23 years old
- People with certain medical conditions that affect the immune system
- Microbiologists who routinely work with isolates of N. meningitidis, the bacteria that cause meningococcal disease
- People at risk because of an outbreak in their community
Recommended Reading: Shingles Vaccine Cost Cvs
Response Rate And Population Characteristics
In total, 5000 invitations letters were sent to adolescents who were eligible for the MenACWY-TT vaccination and their parents. Of them, 181 agreed to participate . The response rate for the questionnaire about symptoms in the week before vaccination was 76.8% . For the questionnaire about symptoms within 7days after vaccination, the response rate was 59.7% . Both questionnaires were returned by 104 adolescents. A third and fourth questionnaire was sent to 28 and 11 adolescents, respectively. Of these, 20 completed the third and 6 completed the fourth questionnaire.
Of all respondents, 50.4% were male in the week before the vaccination, and 50.0% in the week after the vaccination . About 43% of all adolescents reported on having a chronic illness, with eczema , allergies , hay fever and asthma as most reported illness.
What Are The Possible Side Effects Of Meningococcal Vaccines

Some of the most common side effects are swelling, redness, and pain at the site of the injection, along with headache, fever, or tiredness. Serious problems, such as allergic reactions, are rare.
The meningococcal vaccines contains only a small piece of the germ, so it can’t cause meningococcal disease.
Recommended Reading: Can You Get A Tdap Shot At Cvs
Muslims Undergoing The Hajj Or Umrah Pilgrimage
Pilgrims to Saudi Arabia are especially at risk of contracting meningococcal infection. There have been outbreaks in recent years. A proof of immunisation is needed to obtain a visa to go to Saudi Arabia for this purpose.
Note: some pilgrims may have been immunised in the past with an older vaccine which only protected against groups A and C. If you travel to Saudi Arabia again you should have an injection of the newer MenACWY vaccine. Proof of immunisation with MenACWY vaccine given within the preceding three years is now needed to get a new visa to visit Saudi Arabia.
Persons New To Canada
Health care providers who see persons newly arrived in Canada should review the immunization status and update immunization for these individuals. Review of meningococcal vaccination status is particularly important for persons from areas of the world where sickle cell disease is present as persons with sickle cell disease are at risk of serious meningococcal infections. In many countries outside of Canada, conjugate meningococcal vaccines are in limited use. Information on vaccination schedules in other countries can be found on the World Health Organization website. Refer to Immunization of Persons New to Canada in Part 3 for additional general information.
You May Like: Does Cvs Do Tdap Shots
Book A Pharmacy Appointment Today
Need a meningitis vaccination? Book a consultation today.
There are three types of vaccine against meningococcal infection:
- One type of vaccine protects against group C only – the MenC vaccine.
- One type of vaccine called the MenACWY vaccine protects against groups A, C, W and Y.
- One type of vaccine protects against group B only – the MenB vaccine .
The vaccine stimulates your immune system to protect you against meningococcal infection should you become infected with the germs .
Persons With Chronic Diseases
Asplenia
Two doses of Men-C-ACYW vaccine are recommended for persons with anatomic or functional asplenia, including sickle cell disease. When elective splenectomy is planned, all recommended vaccines should ideally be completed at least 2 weeks before surgery if only one dose can be given before surgery, the second dose should be given 8 weeks after the first dose, with a minimum interval of 4 weeks. In the case of an emergency splenectomy, two doses of vaccine should ideally be given beginning 2 weeks after surgery but can be given earlier, before discharge, if the person might not return for vaccination after discharge. Persons one year of age and older with asplenia who have not received Men-C-ACYW vaccine should receive two doses administered 8 weeks apart, with a minimum interval of 4 weeks. In addition, 4CMenB or MenB-fHBP vaccine should be offered. Periodic booster doses with Men-C-ACYW vaccine are also recommended.
Refer to Table 1 for vaccination recommendations of high risk individuals due to underlying conditions. Refer to Booster doses and re-immunization for additional information and Immunization of Persons with Chronic Diseases in Part 3 for additional general information.
Don’t Miss: Cheapest Shingrix Vaccine
What Causes Meningitis And Septicaemia
Meningococcal bacteria are significant causes of meningitis and septicaemia. There are 5 main groups of meningococcal bacteria that can cause meningitis and septicaemia A, B, C, W and Y.
Meningococcal bacteria live in the throats of about 25% of young people without causing any problems at all. The bacteria can spread to other people through coughing, sneezing or kissing. The MenACWY programme’s targeting young people because of the higher risk of the bacteria spreading among young people of the same age.
Young People Eligible For The Menacwy Vaccine
Young people born between 2 July 1996 and 1 July 2002 should have already been offered the vaccine by their GP or in school. If for any reason they missed out they are still eligible for the vaccine from their GP. If you aren’t planning to go to university, it is still important to get the vaccine. You only need to get the MenACWY vaccine once.If you haven’t yet received the vaccine, you can ask your GP.
You May Like: How Much Does Shingles Vaccine Cost At Cvs
Talk With Your Healthcare Provider
Tell your vaccination provider if the person getting the vaccine:
- Has had an allergic reaction after a previous dose of meningococcal ACWY vaccine, or has any severe, life-threatening allergies
In some cases, your health care provider may decide to postpone meningococcal ACWY vaccination until a future visit.
There is limited information on the risks of this vaccine for pregnant or breastfeeding people, but no safety concerns have been identified. A pregnant or breastfeeding person should be vaccinated if indicated.
People with minor illnesses, such as a cold, may be vaccinated. People who are moderately or severely ill should usually wait until they recover before getting meningococcal ACWY vaccine.
Your health care provider can give you more information.
How Is Meningococcal Disease Spread And Who Is Most At Risk

Meningococcal disease is not as contagious as other illnesses, such as a cold or the flu. But it is spread by contact with infected respiratory and throat secretions. That can happen with coughing, kissing, or sneezing.
Because the risk increases with close or prolonged contact with an infected person, family members in the same household and caregivers are at an increased risk. For the same reason, so are college students who live in dormitories.
Recommended Reading: Cvs Tdap Vaccine
All Infants Children And Adults
Any person from 6 weeks of age who wants to protect themselves against meningococcal disease is recommended to receive MenACWY vaccine and MenB vaccine
Any person who wants to protect themselves against invasive meningococcal disease can receive MenACWY and MenB vaccines from as early as 6 weeks of age.
A summary of the recommendations for use of meningococcal vaccines is shown in Table. Recommendations for meningococcal vaccines for people at risk of meningococcal disease. The table shows the type of vaccines that are strongly recommended for specific age groups and special risk groups. See below for brand and dosing recommendations.
Preferred vaccines
Infants aged < 9 months can receive 2 of the 3 MenACWY brands . Infants and children aged 9 months to 2 years can receive any of the 3 MenACWY vaccine brands, following the age-appropriate dosing schedule.
For all people aged 2 years, it is preferable to receive either Menveo or Nimenrix, rather than Menactra.
There is no preference for either Bexsero or Trumenba for people aged 10 years who wish to receive a MenB vaccine. For people aged < 10 years, Bexsero is the only registered MenB vaccine available in Australia.
Recommended dose schedules
For recommended dose schedules for healthy people aged 2 years who wish to receive meningococcal vaccine, see Table. Recommendations for meningococcal vaccines for healthy people aged 2 years, by age and vaccine brand.
Booster doses
How Do We Know The Vaccine’s Safe
All medicines are tested for safety and effectiveness by the Medicines and Healthcare Products Regulatory Agency . The vaccine meets the high safety standards required for it to be used in the UK and other European countries. The vaccine has been given to millions of people worldwide.
Once they’re in use, the safety of vaccines continues to be monitored by the MHRA.
Read Also: Can You Get Tdap At Cvs